Merck's newest Vioxx suit and tug-o-war with Bristol Myers;

> Merck and Bristol-Myers Squibb aren't budging with their market shares of Imclone's Erbitux. Report  

> Another lawsuit against Merck: Florida's attorney general is behind the suit this time, with allegations about Medicaid payments for Vioxx. Report

> A new industry report profiles the pharmaceutical industry in South Africa, examining key trends and demographic information as well as providing detailed data on market size and segmentation. Report

> The Cochrane Collaboration provided Amgen Inc. with a has summary of preliminary results from an independent meta-analysis of patient-level data from a variety of randomized, controlled, clinical studies evaluating erythropoiesis-stimulating agents (ESAs) in cancer patient, which Amgen then submitted to the FDA and the European Medicines Agency. Report

> India's Advinus Therapeutics announced a drug discovery and development collaboration with Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals. Report

> A.P. Pharma says its experimental therapy to prevent nausea and vomiting induced by chemotherapy hit the primary endpoint in three of four assessments outlined in a Phase III comparison trial with with standard therapy. Report

>  APT Pharmaceuticals has completed a $32.3 million Series B financing. The round was led by Three Arch Partners and joined by additional new investors InterWest Partners and Pinnacle Ventures. Report

> Despite all the market turmoil, there are a slew of new investment rounds to report. Link Medicine, Telormedix and Nitec Pharma all reported successful venture rounds. Report 

> The Bill and Melinda Gates Foundation is putting up $168 million to fund research into a new generation of malaria vaccines. Report

> The research world will lose one of its most influential figures when Elias A. Zerhouni (photo) steps down as head of the National Institutes of Health at the end of October. Report

> Pfizer is steadily expanding its presence in the stem cell field. The Wall Street Journal notes that in November the pharma giant will open a regenerative medicine shop in Cambridge, England. Report

And Finally... The brain surgeons already knew this, but the journal Neurology published a study today that found that drugs used to prevent blood clotting, including medications such as warfarin, can increase the risk of bleeding in the brain and hemorrhagic stroke.  Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.